1. Home
  2. SWTX vs CALX Comparison

SWTX vs CALX Comparison

Compare SWTX & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • CALX
  • Stock Information
  • Founded
  • SWTX 2017
  • CALX 1999
  • Country
  • SWTX United States
  • CALX United States
  • Employees
  • SWTX N/A
  • CALX N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • CALX Telecommunications Equipment
  • Sector
  • SWTX Health Care
  • CALX Consumer Discretionary
  • Exchange
  • SWTX Nasdaq
  • CALX Nasdaq
  • Market Cap
  • SWTX 2.2B
  • CALX 2.1B
  • IPO Year
  • SWTX 2019
  • CALX 2010
  • Fundamental
  • Price
  • SWTX $37.59
  • CALX $36.07
  • Analyst Decision
  • SWTX Strong Buy
  • CALX Strong Buy
  • Analyst Count
  • SWTX 5
  • CALX 6
  • Target Price
  • SWTX $67.00
  • CALX $42.50
  • AVG Volume (30 Days)
  • SWTX 1.1M
  • CALX 848.5K
  • Earning Date
  • SWTX 11-12-2024
  • CALX 01-27-2025
  • Dividend Yield
  • SWTX N/A
  • CALX N/A
  • EPS Growth
  • SWTX N/A
  • CALX N/A
  • EPS
  • SWTX N/A
  • CALX N/A
  • Revenue
  • SWTX $135,487,000.00
  • CALX $890,128,000.00
  • Revenue This Year
  • SWTX $3,426.90
  • CALX N/A
  • Revenue Next Year
  • SWTX $88.92
  • CALX $3.13
  • P/E Ratio
  • SWTX N/A
  • CALX N/A
  • Revenue Growth
  • SWTX N/A
  • CALX N/A
  • 52 Week Low
  • SWTX $28.21
  • CALX $26.76
  • 52 Week High
  • SWTX $53.92
  • CALX $45.15
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 46.01
  • CALX 59.14
  • Support Level
  • SWTX $37.26
  • CALX $34.55
  • Resistance Level
  • SWTX $42.51
  • CALX $36.55
  • Average True Range (ATR)
  • SWTX 1.60
  • CALX 1.09
  • MACD
  • SWTX -0.75
  • CALX 0.41
  • Stochastic Oscillator
  • SWTX 4.37
  • CALX 89.12

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About CALX Calix Inc

Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

Share on Social Networks: